Surfactant in lung alveoli stas appearing at gestational age
**Core Concept**
Surfactant is a lipoprotein complex that reduces surface tension within the lung alveoli, facilitating easier lung expansion during breathing. Its appearance is crucial for preventing respiratory distress syndrome (RDS) in preterm infants.
**Why the Correct Answer is Right**
Surfactant production begins in the fetal lung around the 24th week of gestation, with significant amounts produced by the 30th week. This surfactant production is mediated by the enzyme phospholipid biosynthesis, which involves the conversion of phosphatidic acid to phosphatidylcholine. The surfactant then spreads across the alveolar surface, reducing the surface tension and preventing alveolar collapse during expiration.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because surfactant production does not start before the 24th week of gestation.
**Option B:** This option is incorrect because surfactant is not produced in the fetal lung before the 24th week of gestation.
**Option C:** This option is incorrect because surfactant production starts after the 24th week of gestation, not before.
**Option D:** This option is incorrect because surfactant production is not a feature of fetal lung development before the 24th week of gestation.
**Clinical Pearl / High-Yield Fact**
A key clinical correlation is that preterm infants born before the 24th week of gestation are at high risk of developing respiratory distress syndrome (RDS) due to the lack of surfactant production.
**Correct Answer:** A. 24th week.